Is progesterone cream effective or safe for menopause?

Whether progesterone cream is appropriate for managing menopause symptoms depends on individual health factors that cannot be assessed through website content alone. According to current NAMS guidelines, over-the-counter progesterone cream has not been demonstrated to provide reliable endometrial protection or consistent symptom relief comparable to prescription formulations.

What progesterone cream can and cannot do

OTC creams deliver progesterone through the skin, but absorption is low and variable. According to current NAMS guidelines, topical progesterone does not achieve the consistent serum levels required to reliably protect the uterine lining in women using systemic estrogen. Per published clinical guidelines, unopposed estrogen can lead to endometrial proliferation over time, making adequate progestogen exposure a key clinical consideration. Because blood levels remain low and unpredictable with topical creams, per the Endocrine Society, they are not considered an adequate substitute for prescription progestogen therapy in women with an intact uterus.

Progesterone cream may provide mild benefits for some individuals, such as a modest calming effect or marginally improved sleep, but per published clinical guidelines, these effects have not been consistently demonstrated in controlled studies.

Safety considerations

• Low-dose formulations: Per FDA-approved prescribing information, the doses present in OTC creams are low, and systemic side effects such as dizziness, drowsiness, or mood changes are infrequent at these levels.
• No established harm signal: According to current NAMS guidelines, there is no evidence from available data that OTC progesterone creams cause cancer, thrombosis, or cardiovascular events.
• Primary safety concern: According to ACOG, the principal concern with OTC progesterone cream is the risk of false reassurance — individuals may believe the cream provides uterine protection when available evidence does not support that conclusion.

What current clinical practice uses for menopause management

For hot flashes, sleep disturbance, night sweats, vaginal dryness, and endometrial protection, current clinical practice relies on prescription progesterone — specifically micronized oral capsules or vaginal formulations. According to current NAMS guidelines, these formulations achieve consistent therapeutic levels and are supported by substantial clinical evidence. Compounded bioidentical progesterone may be considered in certain clinical situations where commercially available options do not meet a patient's needs, as determined by a prescriber.

Both FDA-approved products (such as estradiol and micronized progesterone) and compounded preparations may contain bioidentical hormones. The term does not indicate superiority of one category over another.

Compounded medications are not FDA-approved. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved medications should be considered first when commercially available options meet patient needs.

Considerations when evaluating progesterone cream

• Mild, low-risk support: Per published clinical guidelines, OTC progesterone cream may be considered by some individuals for mild sleep or mood support, though evidence for these effects is limited.
• Insufficient for symptom management: According to current NAMS guidelines, OTC creams are not considered adequate for managing the primary symptoms of menopause.
• Not appropriate as sole progestogen when using systemic estrogen: Per the Endocrine Society, prescription progesterone is required for endometrial protection in women with a uterus who are using systemic estrogen therapy.

Whether HRT is appropriate depends on individual health factors. A prescriber should determine the best approach based on a patient's complete medical history.